David A. Ostrov - Concepedia

Author

David A. Ostrov

Also Known As

D Ostrov, D. A. Ostrov, D. Ostrov, D.A. Ostrov, David A Ostrov, David A. Ostrov, David A. Ostrov (223782), David Ostrov, Elizabeth Mckinnin, Fontana, Robert John

263

Publications

7.7K

Citations

H-Index

142

Concepts

All Affiliations

University of Florida Florida College Murdoch University Roswell Park Comprehensive Cancer Center Vanderbilt University

About

David A. Ostrov is an author at University of Florida specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	50	3.6K
2	Natural Sciences	12	13	929
3	Allergy	7	7	882
4	Health Sciences	3	3	413
5	Public Health	1	1	54

David A. Ostrov

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire David A. Ostrov, Barry J. Grant, Y.A. Pompeu, Proceedings of the National Academy of Sciences Adaptive Immune SystemImmunologyPathologyImmunodominanceImmunologic Mechanism	2012	415
Independent infections of porcine deltacoronavirus among Haitian children John A. Lednicky, Massimiliano S. Tagliamonte, Sarah K. White, Nature	2021	395
Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents J.A. Hernandez Prada, Anderson J. Ferreira, Michael J. Katovich, Hypertension HypertensionPharmacotherapyChemical BiologyBlood PressureMedicinal Chemistry	2008	267
Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension Anderson J. Ferreira, Vinayak Shenoy, Yoriko Yamazato, American Journal of Respiratory and Critical Care Medicine	2009	247
A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors Debra Akin, S. Keisin Wang, Pouran Habibzadegah-Tari, Autophagy MitophagyImmunologyLc3b LipidationCancer BiologyNegative Impact	2014	244
A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth Vita Golubovskaya, Carl Nyberg, Min Zheng, Journal of Medicinal Chemistry	2008	211
Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual Screening David A. Ostrov, J.A. Hernandez Prada, Patrick Corsino, Antimicrobial Agents and Chemotherapy	2007	200
Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor Matthew J. Huentelman, Jasenka Zubcevic, J.A. Hernandez Prada, Hypertension Molecular DockingMedicinal ChemistryBiochemistryMedicineNatural Sciences	2004	195
A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer Steven N. Hochwald, Carl Nyberg, Min Zheng, Cell Cycle Chemoprevention StrategyPathologyY397 SiteCancer BiologyTumor Biology	2009	168
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms Katherine C. Konvinse, Jason A. Trubiano, Rebecca Pavlos, Journal of Allergy and Clinical Immunology Vancomycin-induced Drug ReactionSystemic SymptomsAllergyImmunodeficienciesImmunology	2019	160

Page 1